In adults with type 2 diabetes and heart disease, it is also used to reduce the risk of major cardiovascular events
Usually, they are simply hitting the physiological wall that all weight loss approaches eventually encounter
The medications currently approved by the FDA for this purpose are Foundayo (orforglipron), Zepbound (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide)
Most patients begin to notice weight loss within the first 14 weeks of starting semaglutide, especially once lifestyle changes like improved diet are incorporated
Presented for research literature review only Xiagedeer B et al
Both Mounjaro and Ozempic are given as weekly injections under the skin (subcutaneously) in the stomach area (abdomen), thigh or upper arm